Tesi’s portfolio company: Kasvu Therapeutics Oy - tesi.fi

Suomeksi

Search for

For companies
For investors
Investments
- Investments
- Companies
- Funds
- Cases
Team
News
Market data
Sustainability
About Tesi

HomeCompaniesKasvu Therapeutics Oy

www.kasvutx.com

Portfolio
Venture Capital Investments

Industry
Health & Life Science

Manager
Miia Kaye

Investment Year
2026

Kasvu Therapeutics develops treatments for depression and other brain disorders, mimicking the therapeutic effects of psychedelics without the hallucinogenic effects.

News
24.9.2026

Kasvu Therapeutics raises EUR 30 million for depression treatment development

Kasvu Therapeutics raises EUR 30 million for depression treatment development

Subscribe

* indicates required

Email Address *

First Name

Last Name

How often would you like to hear from us? *

Daily, if there is new content
Once a week
Once a month

Marketing Permissions *

Accept

By accepting this form, you give Tesi and the partners who produce its newsletter permission to process your information with the newsletters. You can unsubscribe at any time by clicking the link in the footer of our emails or by contacting info@tesi.fi For information about our privacy practices, please visit our website https://www.tesi.fi/en/privacy-policy/.

Grow Together.

Tesi (Finnish Industry Investment Ltd)
Porkkalankatu 1, 00180 Helsinki